The Study on the Effect of Different Administration Methods of Simethicone in Reducing Bubbles During Bowel Preparation
Launched by THE FOURTH AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE · Apr 2, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different ways of giving a medication called simethicone can help reduce gas bubbles during bowel preparation for a colonoscopy. A colonoscopy is a procedure doctors use to check for issues in the colon. The goal of the study is to find the easiest and most effective method for patients to prepare for this important test.
The trial is open to adults aged 18 to 80 who are scheduled for a routine colonoscopy and do not have any serious health issues or allergies related to the treatment. If you choose to participate, you will try out one of the methods for taking simethicone and see how well it works in reducing gas. It’s important to note that the trial is not yet recruiting participants, but it will be an opportunity to contribute to better colonoscopy preparation methods in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing routine colonoscopy at our hospital are aged between 18 to 80 years, including those who meet the Indications for colonoscopy without any absolute contraindications.
- Exclusion Criteria:
- • (1) suffering from pancoliنى, intestinal obstruction, toxic megacolon, severe acute gastrointestinal infection, etc.; (2) individuals with severe dysfunction of the heart, lungs, liver, kidneys, etc.; (3) individuals with a history of allergic reaction to the above gastrointestinal agents; (4) individuals who cannot consent to treatment for epilepsy, etc.
About The Fourth Affiliated Hospital Of Zhejiang University School Of Medicine
The Fourth Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary research, the hospital integrates cutting-edge technology and expert clinical practices to support a wide range of medical studies. Its commitment to ethical standards and patient safety ensures the highest quality of research outcomes, making it a trusted partner in the medical community for both national and international clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yiwu, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported